Suppr超能文献

原发性肿瘤与转移——剖析转移级联反应的不同步骤

Primary tumor and metastasis-sectioning the different steps of the metastatic cascade.

作者信息

Popper Helmut

机构信息

Institute of Pathology, Medical University of Graz, Graz, Austria.

出版信息

Transl Lung Cancer Res. 2020 Oct;9(5):2277-2300. doi: 10.21037/tlcr-20-175.

Abstract

Patients with lung cancer in the majority die of metastases. Treatment options include surgery, chemo- and radiotherapy, targeted therapy by tyrosine kinase inhibitors (TKIs), and immuno-oncologic treatment. Despite the success with these treatment options, cure of lung cancer is achieved in only a very small proportion of patients. In most patients' recurrence and metastasis will occur, and finally kill the patient. Metastasis is a multistep procedure. It requires a change in adhesion of tumor cells for detachment from their neighboring cells. The next step is migration either as single cells [epithelial-mesenchymal transition (EMT)], or as cell clusters (hybrid-EMT or bulk migration). A combination of genetic changes is required to facilitate migration. Then tumor cells have to orient themselves along matrix proteins, detect oxygen concentrations, prevent attacks by immune cells, and induce a tumor-friendly switch of stroma cells (macrophages, myofibroblasts, etc.). Having entered the blood stream tumor cells need to adapt to shear stress, avoid being trapped by coagulation, but also use coagulation in small veins for adherence to endothelia, and express homing molecules for extravasation. Within a metastatic site, tumor cells need a well-prepared niche to establish a metastatic focus. Tumor cells again have to establish a vascular net for maintaining nutrition and oxygen supply, communicate with stroma cells, grow out and set further metastases. In this review the different steps will be discussed with a focus on pulmonary carcinomas. The vast amount of research manuscripts published so far are not easy to analyze: in most reports' single steps of the metastatic cascade are interpreted as evidence for the whole process; for example, migration is interpreted as evidence for metastasis. In lung cancer most often latency periods are shorter, in between 1-5 years. In other cases, despite widespread migration occurs, tumor cells die within the circulation and do not reach a metastatic site. Therefore, migration is a requisite, but does not necessarily predict metastasis. The intention of this review is to point to these different aspects and hopefully provoke research directed into a more functional analysis of the metastatic process.

摘要

大多数肺癌患者死于转移。治疗选择包括手术、化疗和放疗、酪氨酸激酶抑制剂(TKIs)靶向治疗以及免疫肿瘤治疗。尽管这些治疗方法取得了成功,但只有极少数患者能治愈肺癌。在大多数患者中,复发和转移将会发生,并最终导致患者死亡。转移是一个多步骤过程。它需要肿瘤细胞改变黏附性以便从相邻细胞脱离。下一步是作为单个细胞迁移[上皮-间质转化(EMT)],或者作为细胞簇迁移(混合EMT或整体迁移)。需要一系列基因变化来促进迁移。然后肿瘤细胞必须沿着基质蛋白定向,检测氧气浓度,防止免疫细胞攻击,并诱导基质细胞(巨噬细胞、肌成纤维细胞等)向有利于肿瘤的方向转变。进入血流后,肿瘤细胞需要适应剪切应力,避免被凝血困住,但也要利用小静脉中的凝血黏附在内皮上,并表达归巢分子以便外渗。在转移部位,肿瘤细胞需要一个准备充分的微环境来建立转移灶。肿瘤细胞必须再次建立血管网络以维持营养和氧气供应,与基质细胞沟通,生长并形成更多转移灶。在本综述中将会讨论不同步骤,重点是肺癌。到目前为止发表的大量研究手稿并不容易分析:在大多数报告中,转移级联反应的单个步骤被解释为整个过程的证据;例如,迁移被解释为转移的证据。在肺癌中,潜伏期通常较短,在1至5年之间。在其他情况下,尽管发生了广泛的迁移,但肿瘤细胞在循环中死亡,无法到达转移部位。因此,迁移是一个必要条件,但不一定预示着转移。本综述旨在指出这些不同方面,希望能激发针对转移过程进行更功能化分析的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/460e/7653118/6ddc1c8f4b08/tlcr-09-05-2277-f9.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验